Law360, New York (August 31, 2012, 4:38 PM ET) -- Biotech company Verenium Corp. accused a BP PLC unit in New York state court Thursday of failing to properly perform certain enzyme production services under a $1.8 million agreement between the companies, threatening the viability of a new Verenium product.
BP Biofuel North America LLC had negligently failed to maintain its equipment or control its staff to a “commercially reasonable” standard under the bio-fermentation service contract, causing the failure of a number of enzyme production runs, including a critical test necessary to commercialize an upcoming Verenium...
Biotech Co. Says BP Unit Conducted Negligent Enzyme Work
To view the full article, take a free trial now.
